Vestal Point Capital’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.3M Buy
2,000,000
+600,000
+43% +$26.8M 1.99% 17
2026
Q1
$67.5M Buy
+1,400,000
New +$65.3M 1.89% 15
2025
Q1
Sell
-750,000
Closed -$36.2M 81
2024
Q4
$36.2M Buy
750,000
+600,000
+400% +$30.5M 2.14% 18
2024
Q3
$8.64M Buy
+150,000
New +$8.1M 0.66% 36
2024
Q1
Sell
-300,000
Closed -$14.9M 73
2023
Q4
$14.9M Buy
+300,000
New +$14.7M 1.58% 22

Other funds holding SNY

Vestal Point Capital's SNY Position: Q2 2026 in Review

Vestal Point Capital increased its Sanofi (SNY) stake by 43% in Q2 2026, buying an estimated $26.8M and bringing the position to 2,000,000 shares worth $85.3M. The position accounts for 1.99% of the portfolio, ranked #17.

Vestal Point Capital first reported a position in SNY in Q4 2023 and has held it in 5 quarters since. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Vestal Point Capital held 2,000,000 shares of Sanofi worth $85.3M as of Q2 2026.
  • Vestal Point Capital bought 600,000 Sanofi shares in Q2 2026, an estimated $26.8M.
  • Sanofi made up 1.99% of Vestal Point Capital's portfolio in Q2 2026, its #17 holding.
  • Vestal Point Capital first reported a position in Sanofi in Q4 2023 and has held it in 5 quarters since.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.